Kenjiro Kosaki

10.1k total citations
363 papers, 5.2k citations indexed

About

Kenjiro Kosaki is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Kenjiro Kosaki has authored 363 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 194 papers in Molecular Biology, 173 papers in Genetics and 41 papers in Genetics. Recurrent topics in Kenjiro Kosaki's work include Genomic variations and chromosomal abnormalities (55 papers), Genomics and Rare Diseases (36 papers) and Genetics and Neurodevelopmental Disorders (33 papers). Kenjiro Kosaki is often cited by papers focused on Genomic variations and chromosomal abnormalities (55 papers), Genomics and Rare Diseases (36 papers) and Genetics and Neurodevelopmental Disorders (33 papers). Kenjiro Kosaki collaborates with scholars based in Japan, United States and Netherlands. Kenjiro Kosaki's co-authors include Rika Kosaki, Toshiki Takenouchi, Brett Casey, Chiharu Torii, Tomoko Uehara, Nobuhiko Okamoto, Takao Takahashi, Hisato Suzuki, Takao Takahashi and Tsutomu Ogata and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Kenjiro Kosaki

342 papers receiving 5.0k citations

Peers

Kenjiro Kosaki
Kenjiro Kosaki
Citations per year, relative to Kenjiro Kosaki Kenjiro Kosaki (= 1×) peers Stephen P. Robertson

Countries citing papers authored by Kenjiro Kosaki

Since Specialization
Citations

This map shows the geographic impact of Kenjiro Kosaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenjiro Kosaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenjiro Kosaki more than expected).

Fields of papers citing papers by Kenjiro Kosaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenjiro Kosaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenjiro Kosaki. The network helps show where Kenjiro Kosaki may publish in the future.

Co-authorship network of co-authors of Kenjiro Kosaki

This figure shows the co-authorship network connecting the top 25 collaborators of Kenjiro Kosaki. A scholar is included among the top collaborators of Kenjiro Kosaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenjiro Kosaki. Kenjiro Kosaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karnebeek, Clara D.M. van, Anne O’Donnell‐Luria, Gareth Baynam, et al.. (2024). Leaving no patient behind! Expert recommendation in the use of innovative technologies for diagnosing rare diseases. Orphanet Journal of Rare Diseases. 19(1). 357–357. 7 indexed citations
2.
Takahashi, Ikuko, Atsuko Noguchi, Yoko Sato, et al.. (2024). A novel missense variant of <i>FGD1</i> disrupts critical cysteine residues of the FYVE domain in Japanese siblings with Aarskog–Scott syndrome. Clinical Pediatric Endocrinology. 33(1). 39–42.
4.
Takahashi, Satoru, et al.. (2023). miR-514a promotes neuronal development in human iPSC-derived neurons. Frontiers in Cell and Developmental Biology. 11. 1096463–1096463.
5.
Kabe, Yasuaki, Susumu Uchiyama, Yuka W. Iwasaki, et al.. (2022). Pro108Ser mutation of SARS-CoV-2 3CLpro reduces the enzyme activity and ameliorates the clinical severity of COVID-19. Scientific Reports. 12(1). 1299–1299. 18 indexed citations
6.
Suzuki, Hisato, Kana Aoki, Kenji Kurosawa, et al.. (2022). De novo non-synonymous CTR9 variants are associated with motor delay and macrocephaly: human genetic and zebrafish experimental evidence. Human Molecular Genetics. 31(22). 3846–3854. 1 indexed citations
7.
Sakamoto, Kenichi, et al.. (2022). Familial hemophagocytic lymphohistiocytosis syndrome due to lysinuric protein intolerance: a patient with a novel compound heterozygous pathogenic variant in SLC7A7. International Journal of Hematology. 116(4). 635–638. 4 indexed citations
8.
Okamoto, Nobuhiko, Fuyuki Miya, Tatsuhiko Tsunoda, et al.. (2021). Four pedigrees with aminoacyl-tRNA synthetase abnormalities. Neurological Sciences. 43(4). 2765–2774. 10 indexed citations
9.
Tozawa, Takenori, Akira Nishimura, Takeshi Yoshida, et al.. (2021). Complex hereditary spastic paraplegia associated with episodic visual loss caused by ACO2 variants. Human Genome Variation. 8(1). 4–4. 4 indexed citations
10.
Sugihara, Eiji, Satoru Osuka, Takatsune Shimizu, et al.. (2020). The Inhibitor of Apoptosis Protein Livin Confers Resistance to Fas-Mediated Immune Cytotoxicity in Refractory Lymphoma. Cancer Research. 80(20). 4439–4450. 10 indexed citations
11.
Kubo, Akiharu, Takashi Sasaki, Hisato Suzuki, et al.. (2019). Clonal Expansion of Second-Hit Cells with Somatic Recombinations or C>T Transitions Form Porokeratosis in MVD or MVK Mutant Heterozygotes. Journal of Investigative Dermatology. 139(12). 2458–2466.e9. 33 indexed citations
12.
Hori, Ikumi, Fuyuki Miya, Yutaka Negishi, et al.. (2018). A novel homozygous missense mutation in the SH3-binding motif of STAMBP causing microcephaly-capillary malformation syndrome. Journal of Human Genetics. 63(9). 957–963. 10 indexed citations
13.
Okada, Yukinori, Yukihide Momozawa, Saori Sakaue, et al.. (2018). Deep whole-genome sequencing reveals recent selection signatures linked to evolution and disease risk of Japanese. Nature Communications. 9(1). 1631–1631. 84 indexed citations
14.
Okamoto, Nobuhiko, Fuyuki Miya, Tatsuhiko Tsunoda, et al.. (2017). Novel MCA/ID syndrome with ASH1L mutation. American Journal of Medical Genetics Part A. 173(6). 1644–1648. 29 indexed citations
15.
Mitsuhashi, Takayuki, Junzo Yonemoto, Hirohito Sone, et al.. (2010). In utero exposure to dioxin causes neocortical dysgenesis through the actions of p27 Kip1. Proceedings of the National Academy of Sciences. 107(37). 16331–16335. 22 indexed citations
16.
Torii, Chiharu, Rika Kosaki, Kenji Kurosawa, et al.. (2007). Screening for Alagille Syndrome Mutations in the JAG1 and NOTCH2 Genes Using Denaturing High-Performance Liquid Chromatography. Genetic Testing. 11(3). 216–227. 7 indexed citations
17.
Udaka, Toru, Issei Imoto, Yoshinori Aizu, et al.. (2007). Multiplex PCR/Liquid Chromatography Assay for Screening of Subtelomeric Rearrangements. Genetic Testing. 11(3). 241–248. 3 indexed citations
18.
Udaka, Toru, Kenji Kurosawa, Kosuke Izumi, et al.. (2006). Screening for Partial Deletions in the CREBBP Gene in Rubinstein–Taybi Syndrome Patients Using Multiplex PCR/Liquid Chromatography. Genetic Testing. 10(4). 265–271. 12 indexed citations
19.
Aramaki, Michihiko, Toru Udaka, Chiharu Torii, et al.. (2006). Screening for CHARGE Syndrome Mutations in the CHD7 Gene Using Denaturing High-Performance Liquid Chromatography. Genetic Testing. 10(4). 244–251. 12 indexed citations
20.
Udaka, Toru, Chiharu Torii, Daisuke Takahashi, et al.. (2005). Comprehensive Screening of the Thiopurine Methyltransferase Polymorphisms by Denaturing High-Performance Liquid Chromatography. Genetic Testing. 9(2). 85–92. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026